Intercept Pharmaceuticals, Inc.


Updates from The Motley Fool

Latest updates on Intercept Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Intercept Pharmaceuticals.
5 Top Stocks for January

Start the year right by buying a piece of these five compelling businesses.



Stock Performance

View Interactive ICPT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Intercept Pharmaceuticals.
Current Price: $69.96
Prev Close: $69.99
Open: $69.50
Bid: $69.50
Ask: $72.00
Day's Range: $69.48 - $70.58
52wk Range: $51.05 - $135.59
Volume: 201,413
Avg Vol 601,225
Market Cap: $2B
P/E (ttm): -5.00
EPS (ttm): ($13.99)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Intercept Pharmaceuticals.
CAPS Rating 4 out of 5
 
89 Outperform
32 Underperform
CAPS All Stars
 
25 Outperform
5 Underperform

How do you think Intercept Pharmaceuticals will perform against the market?



You pick for Intercept Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark Pruzanski, CEO

25% Approve

Based on 10 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Intercept Pharmaceuticals.

Intercept Pharmaceuticals, Inc.

  • Exchange: NASDAQ